HomeNewsIndiaCOVID-19: Health Ministry issues revised home isolation guidelines

COVID-19: Health Ministry issues revised home isolation guidelines

However, patients suffering from immune-compromised status (like HIV, transplant recipients, cancer therapy) are not eligible for home isolation, the revised guidelines stated.

July 03, 2020 / 11:24 IST
Story continues below Advertisement

As a large number of people showing no symptoms being detected for COVID-19, the Union health ministry on Thursday revised the home isolation guidelines to include asymptomatic positive patients in the list of mild or pre-symptomatic coronavirus infection cases.

However, patients suffering from immune-compromised status (like HIV, transplant recipients, cancer therapy) are not eligible for home isolation, the revised guidelines stated.

Story continues below Advertisement

Also, elderly patients aged more than 60 years and those with co-morbid conditions such as hypertension, diabetes, heart disease, chronic lung/liver/kidney disease and cerebro-vascular disease among others shall only be allowed home isolation after proper evaluation by the treating medical officer.

Patients under home isolation will stand discharged after 10 days of onset of symptoms and no fever for three days, the guidelines stated.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show